Morgan Stanley Has Lowered Expectations for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price target decreased by equities research analysts at Morgan Stanley from $1,550.00 to $1,475.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical instruments supplier’s stock. Morgan Stanley’s price objective would indicate a potential upside of 4.15% from the stock’s current price.

Several other brokerages also recently issued reports on MTD. Wells Fargo & Company raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price for the company in a report on Monday, December 15th. Stifel Nicolaus boosted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday, November 10th. Citigroup boosted their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Finally, Wall Street Zen cut shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $1,435.42.

Mettler-Toledo International Stock Performance

Shares of Mettler-Toledo International stock traded up $35.40 during trading hours on Tuesday, reaching $1,416.28. The company’s stock had a trading volume of 31,296 shares, compared to its average volume of 138,563. The stock has a market cap of $28.93 billion, a P/E ratio of 33.66, a price-to-earnings-growth ratio of 4.09 and a beta of 1.42. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,525.17. The company’s 50 day simple moving average is $1,420.24 and its 200 day simple moving average is $1,361.25.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The company had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same period last year, the firm earned $12.41 EPS. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. On average, sell-side analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other news, CEO Patrick Kaltenbach sold 2,000 shares of the stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the completion of the sale, the chief executive officer owned 3,670 shares of the company’s stock, valued at $5,367,375. This represents a 35.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gerry Keller sold 236 shares of the stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the transaction, the insider directly owned 159 shares in the company, valued at $225,554.22. The trade was a 59.75% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 10,316 shares of company stock valued at $15,270,015. Corporate insiders own 0.77% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in MTD. Geneos Wealth Management Inc. lifted its holdings in shares of Mettler-Toledo International by 83.3% in the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after purchasing an additional 30 shares in the last quarter. Vontobel Holding Ltd. increased its stake in Mettler-Toledo International by 31.7% in the 2nd quarter. Vontobel Holding Ltd. now owns 494 shares of the medical instruments supplier’s stock valued at $580,000 after buying an additional 119 shares during the last quarter. Blair William & Co. IL boosted its stake in Mettler-Toledo International by 17.4% during the second quarter. Blair William & Co. IL now owns 897 shares of the medical instruments supplier’s stock valued at $1,054,000 after buying an additional 133 shares during the period. IFP Advisors Inc lifted its stake in Mettler-Toledo International by 542.9% in the second quarter. IFP Advisors Inc now owns 90 shares of the medical instruments supplier’s stock worth $106,000 after acquiring an additional 76 shares during the period. Finally, Aberdeen Group plc boosted its stake in Mettler-Toledo International by 9.1% during the 2nd quarter. Aberdeen Group plc now owns 17,910 shares of the medical instruments supplier’s stock valued at $21,039,000 after purchasing an additional 1,496 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.